Shares of Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) rose 15.6% during mid-day trading on Friday . The company traded as high as C$16.82 and last traded at C$16.67. Approximately 106,840 shares changed hands during trading, an increase of 292% from the average daily volume of 27,226 shares. The stock had previously closed at C$14.42.
Cipher Pharmaceuticals Trading Up 16.4%
The company has a market capitalization of C$425.71 million, a PE ratio of 25.04 and a beta of 1.33. The company has a debt-to-equity ratio of 11.75, a quick ratio of 2.67 and a current ratio of 1.30. The business has a fifty day moving average price of C$14.86 and a 200 day moving average price of C$14.92.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.
Featured Stories
- Five stocks we like better than Cipher Pharmaceuticals
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
